2022 BioFest Invest
Event summary
Cooley is proud to sponsor BioFest Invest, which brings together investors from across the nation and Texas bioscience companies seeking investment funding, while sharing best practices, connections and valuable advice. After a rigorous screening process, investors will have an opportunity to review selected company applications prior to the event to determine which companies they are interested in visiting. During the event, investors will be able to view company pitches and connect with company representatives live or after the event. Attendees will also have access to speakers and panelists on valuable topics relevant to bioscience companies. One-on-one networking meetings are available throughout the event via video chat rooms.
Cooley Partner Karen Deschaine is a featured speaker. She will present on the topic “Sources of Funding: Early Stage Investment Options and Grant Funding”.
Event details and registration
For more information, please email Adam Zubairi.
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.